These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

62 related items for PubMed ID: 8883617

  • 1. Antigenic determinants on HIV-1 envelope glycoproteins: a dickens of a time with oligomer twist.
    Kent KA, Robinson J.
    AIDS; 1996; 10 Suppl A():S107-14. PubMed ID: 8883617
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Evaluation of a recombinant latex agglutination test for HIV-1].
    Pena MJ, Lafarga B, Pérez MC.
    Enferm Infecc Microbiol Clin; 1991; 9(6):380-1. PubMed ID: 1932250
    [No Abstract] [Full Text] [Related]

  • 7. Antibody neutralization and escape by HIV-1.
    Wei X, Decker JM, Wang S, Hui H, Kappes JC, Wu X, Salazar-Gonzalez JF, Salazar MG, Kilby JM, Saag MS, Komarova NL, Nowak MA, Hahn BH, Kwong PD, Shaw GM.
    Nature; 2003 Mar 20; 422(6929):307-12. PubMed ID: 12646921
    [Abstract] [Full Text] [Related]

  • 8. Human immunodeficiency virus type 1 subtype E envelope recombinant peptides containing naturally immunogenic epitopes.
    Chang SY, Vithayasai V, Vithayasai P, Essex M, Lee TH.
    J Infect Dis; 2000 Aug 20; 182(2):442-50. PubMed ID: 10915074
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The antigenic structure of the HIV gp120 envelope glycoprotein.
    Wyatt R, Kwong PD, Desjardins E, Sweet RW, Robinson J, Hendrickson WA, Sodroski JG.
    Nature; 1998 Jun 18; 393(6686):705-11. PubMed ID: 9641684
    [Abstract] [Full Text] [Related]

  • 11. An early taste of functional glycomics.
    Mrksich M.
    Chem Biol; 2004 Jun 18; 11(6):739-40. PubMed ID: 15217604
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission.
    Derdeyn CA, Decker JM, Bibollet-Ruche F, Mokili JL, Muldoon M, Denham SA, Heil ML, Kasolo F, Musonda R, Hahn BH, Shaw GM, Korber BT, Allen S, Hunter E.
    Science; 2004 Mar 26; 303(5666):2019-22. PubMed ID: 15044802
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites.
    Kwong PD, Doyle ML, Casper DJ, Cicala C, Leavitt SA, Majeed S, Steenbeke TD, Venturi M, Chaiken I, Fung M, Katinger H, Parren PW, Robinson J, Van Ryk D, Wang L, Burton DR, Freire E, Wyatt R, Sodroski J, Hendrickson WA, Arthos J.
    Nature; 2002 Dec 12; 420(6916):678-82. PubMed ID: 12478295
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity.
    Braibant M, Brunet S, Costagliola D, Rouzioux C, Agut H, Katinger H, Autran B, Barin F.
    AIDS; 2006 Oct 03; 20(15):1923-30. PubMed ID: 16988513
    [Abstract] [Full Text] [Related]

  • 19. HIV vaccines. Magic of the occult?
    Montefiori D, Moore JP.
    Science; 1999 Jan 15; 283(5400):336-7. PubMed ID: 9925493
    [No Abstract] [Full Text] [Related]

  • 20. HIV-1 neutralization: mechanisms and relevance to vaccine design.
    Zwick MB, Burton DR.
    Curr HIV Res; 2007 Nov 15; 5(6):608-24. PubMed ID: 18045117
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.